Figure AI Stock: Can You Buy the Robot Darling?

Few companies in the humanoid race have generated as much investor curiosity as Figure AI, and for good reason. The company behind the Figure 02 and Figure 03 humanoids has gone from stealth startup to a $39 billion valuation in roughly three years, with backing from Nvidia, Microsoft, and Jeff Bezos. The catch, and the reason “Figure AI stock” is one of the most-searched robot questions right now: the company is private, and there is no ticker to buy. Here is the honest map of the situation, including where the new Infinite Money Glitch presentation fits in. Our full teardown covers the pitch.

What Figure Actually Is

Figure AI builds general-purpose humanoids for commercial deployment: warehouse work, manufacturing, and eventually the home. Its robots have shipped to real customers, including a BMW pilot on automotive assembly lines, and the company’s revenue-bearing deployments are a genuine differentiator against lab demos. The $39 billion valuation the presentation cites matches the widely reported figure from its latest round, and the investor list it names, Nvidia, Microsoft, and Jeff Bezos personally, is accurate.

The company also matters as a demand signal. If the world’s most sophisticated AI investors are placing nine-figure bets on general-purpose humanoids at this valuation, the supplier market underneath those robots is not speculative; it is already being procurement-scaled. That is the thread the Infinite Money Glitch pitch pulls when it mentions Figure.

Where Figure Appears in the Pitch

The presentation references Figure in its third report, on an edge-AI chip company: “Its technology already sits inside more than a billion devices, and it just built a dedicated chip for AI robots running 700 trillion calculations a second. Humanoid robot makers are already signing on as partners, including Figure.”

That is a real relationship in the industry: chip makers court the humanoid companies because every robot carries dozens of chips for vision, position sensing, and motor control. The pitch’s point is that whoever supplies Figure supplies everyone else too, because the component stack is shared across the whole field, from Optimus to Figure to Apptronik’s Apollo. Our industrial automation piece breaks down what that stack contains.

The Honest Ways to Get Robot Exposure

Since Figure itself cannot be bought, the routes around it are the menu:

The backers. Nvidia (NVDA) and Microsoft (MSFT) are public investors in Figure, though their stakes are tiny fractions of enormous companies. Owning them for their Figure exposure is not a coherent thesis, but it does mean the public market participates in Figure’s upside indirectly.

The suppliers. The component layer, image sensors, magnetic position chips, motor controllers, power electronics, is the shared infrastructure across every humanoid maker, private or public. The pitch’s core argument, “the biggest fortunes have not actually gone to the people who bought Tesla stock. They went to the people who owned his suppliers,” applies to the Figure story exactly as it did to the Tesla story, and the supplier names are the content of the paid reports.

The customers. Companies deploying robots, like the logistics and auto names running Figure and Agility pilots, get labor-cost savings rather than robot revenues.

Private-market access. Pre-IPO shares exist in secondary markets for accredited investors, at valuations that already price in a great deal of success. That is a different risk class than buying a public supplier, and not one this pitch addresses.

How Private-Company Valuations Actually Behave

Because Figure is the leading private name in the humanoid race, a short honest primer on private marks helps readers calibrate every claim in this space. Private valuations are negotiated between a company and a small set of investors at a moment in time, with terms (liquidation preferences, ratchets, board seats) that the headline number never captures, and they can drift far from what any open market would pay, in both directions. The venture market’s humanoid valuations have risen steeply across funding rounds, which is the fact the pitch’s energy borrows, but a high private mark does not establish commercial traction: revenue, deployment volumes, and customer retention are the numbers that matter, and for most humanoid firms those are still small relative to the valuations. For the public investor the practical takeaways are two. First, there is no way to buy a private mark; the only public exposure to Figure-adjacent economics is through its partners and suppliers, some public, some not, and the supply-chain route carries its own company-specific risks. Second, every “Figure is worth X” claim in a pitch is a data point about fundraising sentiment, not about the robots. Both takeaways reward the reader who separates the technology’s genuine progress from the market’s enthusiasm for it, which is the whole skill this genre demands.

What to Watch

Figure is the most IPO-shaped name in the private humanoid field: large valuation, brand-name backers, commercial deployments, and a founder, Brett Adcock, who is publicly vocal. An IPO would be the moment the “can you buy Figure” question changes, and it would also be a liquidity event that reprices the whole supplier complex.

Until then, the honest answer to the search query is: no direct stock exists, the backers are diluted, and the cleanest public-market expression of the humanoid boom is the component supply chain underneath all of the private companies at once. The pitch sells its own version of that answer for $49 with a 90-day guarantee; whether its hidden names are better than your own diligence is the bet.

For the wider field, see our humanoid robot companies scorecard and the how-to-invest guide. Figure is the company everyone wants to own. The market has not yet decided to let them.

NewsletterVetter is an independent publication. We receive compensation from some of the services we review through affiliate links. Nothing on this site is investment advice. Always do your own research.